{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:36:51Z","timestamp":1793111811488,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To estimate the clinical effectiveness, as determined by positive pregnancy test, of letrozole compared with clomiphene citrate for ovarian stimulation in patients with unexplained infertility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis of data from electronic databases including Ovid-MEDLINE, EMBASE, Scopus, Cochrane Database of Systematic Reviews, Cochrane Register of Controlled Trials, Database of Abstracts of Reviews of Effects, and ClinicalTrials.gov.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We searched for concepts of unexplained infertility, letrozole, clomiphene citrate, and clinical outcomes including pregnancy and live birth. Studies were included if they were randomized controlled trials (RCTs) comparing clomiphene citrate with letrozole in patients with unexplained infertility. Eight RCTs including 2,647 patients with unexplained infertility were included. Primary outcome was positive pregnancy test per patient. Secondary outcomes included positive pregnancy test per cycle, clinical pregnancy, live birth, spontaneous miscarriage, twin gestation, mean serum estradiol (E2), endometrial thickness, and number of dominant follicles. The Cochrane Q test and Higgin's I\n                      <jats:sup>2<\/jats:sup>\n                      were used to assess heterogeneity. Random effects models were used to obtain pooled relative risks (RR) and 95% CIs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>\n                      In analysis per patient, there was no significant difference in positive pregnancy test between patients treated with letrozole compared with clomiphene citrate (24% vs 23%, pooled RR 1.08, 95% CI 0.85\u20131.36). Significant heterogeneity was noted between studies (I\n                      <jats:sup>2<\/jats:sup>\n                      =60.8%). There were no significant differences in clinical pregnancy (pooled RR 1.15, 95% CI 0.71\u20131.85), live birth (pooled RR 0.94, 95% CI 0.83\u20131.08), spontaneous miscarriage (pooled RR 0.92, 95% CI 0.61\u20131.38), or twin gestation (pooled RR 0.81, 95% CI 0.39\u20131.68). Mean serum E2 was significantly lower in the letrozole group than in the clomiphene citrate group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Although limited by heterogeneity, studies of ovarian stimulation in women with unexplained infertility show no difference in clinical outcomes between letrozole and clomiphene citrate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000003105","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T16:24:50Z","timestamp":1549988690000},"page":"437-444","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Letrozole Compared With Clomiphene Citrate for Unexplained Infertility"],"prefix":"10.1097","volume":"133","author":[{"given":"Ashley M.","family":"Eskew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn S.","family":"Bedrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn R. T.","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A.","family":"Colditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Methodius G.","family":"Tuuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Jungheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261027","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(02)09417-5","article-title":"Female subfertility","volume":"360","author":"Evers","year":"2002","journal-title":"Lancet"},{"key":"R2-20261027","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.fertnstert.2016.02.001","article-title":"Evidence-based approach to unexplained infertility: a systematic review","volume":"105","author":"Gunn","year":"2016","journal-title":"Fertil Steril"},{"key":"R3-20261027","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jsgi.2004.03.006","article-title":"Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation","volume":"11","author":"Mitwally","year":"2004","journal-title":"J Soc Gynecol Investig"},{"key":"R4-20261027","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/deg311","article-title":"Aromatase inhibition reduces gonadotropin dose required for controlled ovarian stimulation in women with unexplained infertility","volume":"18","author":"Mitwally","year":"2003","journal-title":"Hum Reprod"},{"key":"R5-20261027","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/humrep\/del267","article-title":"Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study","volume":"21","author":"Palomba","year":"2006","journal-title":"Hum Reprod"},{"key":"R6-20261027","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0015-0282(16)55973-1","article-title":"Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment","volume":"59","author":"Massai","year":"1993","journal-title":"Fertil Steril"},{"key":"R7-20261027","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.fertnstert.2018.01.008","article-title":"Ovarian stimulation in infertile women treated with the use of intrauterine insemination: a cohort study from China","volume":"109","author":"Huang","year":"2018","journal-title":"Fertil Steril"},{"key":"R8-20261027","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ajog.2004.08.013","article-title":"Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation","volume":"192","author":"Mitwally","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20261027","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N Engl J Med"},{"key":"R11-20261027","first-page":"614","article-title":"Superovulation and intrauterine insemination vs. superovulation alone in the treatment of unexplained infertility. A randomized study","volume":"41","author":"Arcaini","year":"1996","journal-title":"J Reprod Med"},{"key":"R12-20261027","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/dmp048","article-title":"World Health Organization reference values for human semen characteristics","volume":"16","author":"Cooper","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R13-20261027","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R14-20261027","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R15-20261027","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.fertnstert.2006.03.044","article-title":"Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial","volume":"86","author":"Barroso","year":"2006","journal-title":"Fertil Steril"},{"key":"R16-20261027","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1414827","article-title":"Letrozole, gonadotropin, or clomiphene for unexplained infertility","volume":"373","author":"Diamond","year":"2015","journal-title":"N Engl J Med"},{"key":"R17-20261027","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1477-7827-9-84","article-title":"Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial","volume":"9","author":"Fouda","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"R18-20261027","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/01443615.2010.497873","article-title":"Clomiphene citrate or aromatase inhibitors combined with gonadotropins for superovulation in women undergoing intrauterine insemination: a prospective randomised trial","volume":"30","author":"Badawy","year":"2010","journal-title":"J Obstet Gynaecol"},{"key":"R19-20261027","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00404-012-2478-0","article-title":"Letrozole versus clomiphene citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial","volume":"286","author":"Ibrahim","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"R20-20261027","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.fertnstert.2008.06.013","article-title":"Clomiphene citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized trial","volume":"92","author":"Badawy","year":"2009","journal-title":"Fertil Steril"},{"key":"R21-20261027","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00016340802638199","article-title":"Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility","volume":"88","author":"Badawy","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R22-20261027","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.fertnstert.2004.04.070","article-title":"A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation","volume":"82","author":"Al-Fozan","year":"2004","journal-title":"Fertil Steril"},{"key":"R23-20261027","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jog.12393","article-title":"Letrozole versus clomiphene citrate for unexplained infertility: a systematic review and meta-analysis","volume":"40","author":"Liu","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"R24-20261027","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/OGX.0b013e31817d4e8d","article-title":"Treatment of unexplained infertility with aromatase inhibitors or clomiphene citrate: a systematic review and meta-analysis","volume":"63","author":"Polyzos","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"R25-20261027","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.cct.2011.07.009","article-title":"Estimating rates of multiple gestation pregnancies: sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial","volume":"32","author":"Diamond","year":"2011","journal-title":"Contemp Clin Trials"},{"key":"R26-20261027","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.fertnstert.2008.04.065","article-title":"Extended letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol","volume":"92","author":"Badawy","year":"2009","journal-title":"Fertil Steril"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201903000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:03:18Z","timestamp":1793109798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201903000-00005"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003105","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"2018-09-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}